Bellus Health to Present at Bloom Burton & Co. Healthcare Investor Conference

LAVAL, QC, June 6, 2012 /CNW/ - BELLUS Health Inc. (TSX: BLU) ("BELLUS Health" or the "Company") today advised that Roberto Bellini, President and Chief Executive Officer, will present at the 2012 Bloom Burton & Co. Healthcare Investor Conference. The presentation will take place at 4:00 pm Eastern Time on Thursday, June 21st, 2012. The conference is being held at the Toronto Board of Trade in Toronto, Ontario.

The Bloom Burton & Co. Healthcare Investor Conference brings together U.S., Canadian and European investors who are interested in the latest developments in the Canadian healthcare sector. Attendees will have an opportunity to obtain corporate updates from the premier Canadian public and private companies through presentations and break-out Q&A sessions.

About BELLUS Health (www.bellushealth.com)

BELLUS Health is a development-focused healthcare company concentrating on products that provide innovative health solutions and address critical unmet medical needs. The Company, in collaboration with its partner, Celtic Therapeutics Inc., is currently advancing its novel drug candidate KIACTA™, through a Phase III trial for the treatment of AA amyloidosis, an orphan indication resulting in renal dysfunction that often rapidly leads to dialysis and eventually death. AA amyloidosis affects approximately 50,000 individuals in the United States, Europe and Japan.

SOURCE BELLUS HEALTH INC.

For further information:

Jonathan Ross
TMX Equicom
416-815-0700 ext. 248 | jross@equicomgroup.com

Organization Profile

BELLUS HEALTH INC.

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890